SEC INSIDER TRANSACTIONS

FLEX LTD. (FLEX) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

FLEX · FLEX LTD.

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 41 filings · fetched 2026-11-13T17:57:38Z

Recent reported activity

0purchase rows on this page

9sale rows on this page

134matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-05-26Filed 2026-05-26	Tan Kwang HooiOfficer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The sale(s) reported in this Form 4 were effected pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on December 8, 2025. F2 Includes the following: (1) 23,981 unvested restricted share units ("RSUs"), which will vest in two equal annual installments beginning on June 12, 2026; (2) 21,964 unvested RSUs, which will vest in three equal annual installments beginning on June 12, 2026; (3) 16,195 unvested RSUs, which will vest on June 14, 2026; and (4) 72,578 unvested RSUs, which will vest on September 25, 2027. F3 Each unvested RSU represents a contingent right to receive one unrestricted, fully transferable share for each vested RSU which has not been previously forfeited. References: F1, F2, F3	S Sale (market/private)Ordinary Shares · Non-derivative	17,500D	135.93	Direct	Form 4 ↗0001929609-26-000006
2026-05-22Filed 2026-05-26	Advaithi RevathiDirector · Officer · Chief Executive Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on February 20, 2026. F2 Price reflects weighted average sales price; actual sales prices ranged from $128.73 to $129.578. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F3 Price reflects weighted average sales price; actual sales prices ranged from $129.762 to $130.76. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F4 Price reflects weighted average sales price; actual sales prices ranged from $130.83 to $131.77. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F5 Price reflects weighted average sales price; actual sales prices ranged from $131.84 to $132.838. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F6 Price reflects weighted average sales price; actual sales prices ranged from $132.84 to $133.829. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F7 Price reflects weighted average sales price; actual sales prices ranged from $133.84 to $134.159. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F8 Includes the following: (1) 109,478 unvested restricted share units ("RSUs"), which will vest in two equal annual installments beginning on June 12, 2026; (2) 94,675 unvested RSUs, which will vest in three equal annual installments beginning on June 12, 2026; and (3) 85,021 unvested RSUs, which will vest on June 14, 2026. F9 Each unvested RSU represents a contingent right to receive one unrestricted, fully transferable share for each vested RSU which has not been previously forfeited. F10 Shares held by a grantor retained annuity trust ("GRAT") of which the reporting person is the trustee. References: F1, F7, F8, F9	S Sale (market/private)Ordinary Shares · Non-derivative	1,671D	134.0329	Direct	Form 4 ↗0001649101-26-000005
2026-05-22Filed 2026-05-26	Advaithi RevathiDirector · Officer · Chief Executive Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on February 20, 2026. F2 Price reflects weighted average sales price; actual sales prices ranged from $128.73 to $129.578. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F3 Price reflects weighted average sales price; actual sales prices ranged from $129.762 to $130.76. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F4 Price reflects weighted average sales price; actual sales prices ranged from $130.83 to $131.77. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F5 Price reflects weighted average sales price; actual sales prices ranged from $131.84 to $132.838. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F6 Price reflects weighted average sales price; actual sales prices ranged from $132.84 to $133.829. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F7 Price reflects weighted average sales price; actual sales prices ranged from $133.84 to $134.159. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F8 Includes the following: (1) 109,478 unvested restricted share units ("RSUs"), which will vest in two equal annual installments beginning on June 12, 2026; (2) 94,675 unvested RSUs, which will vest in three equal annual installments beginning on June 12, 2026; and (3) 85,021 unvested RSUs, which will vest on June 14, 2026. F9 Each unvested RSU represents a contingent right to receive one unrestricted, fully transferable share for each vested RSU which has not been previously forfeited. F10 Shares held by a grantor retained annuity trust ("GRAT") of which the reporting person is the trustee. References: F1, F6	S Sale (market/private)Ordinary Shares · Non-derivative	54,701D	133.2979	Direct	Form 4 ↗0001649101-26-000005
2026-05-22Filed 2026-05-26	Advaithi RevathiDirector · Officer · Chief Executive Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on February 20, 2026. F2 Price reflects weighted average sales price; actual sales prices ranged from $128.73 to $129.578. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F3 Price reflects weighted average sales price; actual sales prices ranged from $129.762 to $130.76. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F4 Price reflects weighted average sales price; actual sales prices ranged from $130.83 to $131.77. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F5 Price reflects weighted average sales price; actual sales prices ranged from $131.84 to $132.838. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F6 Price reflects weighted average sales price; actual sales prices ranged from $132.84 to $133.829. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F7 Price reflects weighted average sales price; actual sales prices ranged from $133.84 to $134.159. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F8 Includes the following: (1) 109,478 unvested restricted share units ("RSUs"), which will vest in two equal annual installments beginning on June 12, 2026; (2) 94,675 unvested RSUs, which will vest in three equal annual installments beginning on June 12, 2026; and (3) 85,021 unvested RSUs, which will vest on June 14, 2026. F9 Each unvested RSU represents a contingent right to receive one unrestricted, fully transferable share for each vested RSU which has not been previously forfeited. F10 Shares held by a grantor retained annuity trust ("GRAT") of which the reporting person is the trustee. References: F1, F5	S Sale (market/private)Ordinary Shares · Non-derivative	20,327D	132.5661	Direct	Form 4 ↗0001649101-26-000005
2026-05-22Filed 2026-05-26	Advaithi RevathiDirector · Officer · Chief Executive Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on February 20, 2026. F2 Price reflects weighted average sales price; actual sales prices ranged from $128.73 to $129.578. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F3 Price reflects weighted average sales price; actual sales prices ranged from $129.762 to $130.76. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F4 Price reflects weighted average sales price; actual sales prices ranged from $130.83 to $131.77. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F5 Price reflects weighted average sales price; actual sales prices ranged from $131.84 to $132.838. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F6 Price reflects weighted average sales price; actual sales prices ranged from $132.84 to $133.829. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F7 Price reflects weighted average sales price; actual sales prices ranged from $133.84 to $134.159. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F8 Includes the following: (1) 109,478 unvested restricted share units ("RSUs"), which will vest in two equal annual installments beginning on June 12, 2026; (2) 94,675 unvested RSUs, which will vest in three equal annual installments beginning on June 12, 2026; and (3) 85,021 unvested RSUs, which will vest on June 14, 2026. F9 Each unvested RSU represents a contingent right to receive one unrestricted, fully transferable share for each vested RSU which has not been previously forfeited. F10 Shares held by a grantor retained annuity trust ("GRAT") of which the reporting person is the trustee. References: F1, F4	S Sale (market/private)Ordinary Shares · Non-derivative	1,360D	131.2026	Direct	Form 4 ↗0001649101-26-000005
2026-05-22Filed 2026-05-26	Advaithi RevathiDirector · Officer · Chief Executive Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on February 20, 2026. F2 Price reflects weighted average sales price; actual sales prices ranged from $128.73 to $129.578. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F3 Price reflects weighted average sales price; actual sales prices ranged from $129.762 to $130.76. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F4 Price reflects weighted average sales price; actual sales prices ranged from $130.83 to $131.77. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F5 Price reflects weighted average sales price; actual sales prices ranged from $131.84 to $132.838. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F6 Price reflects weighted average sales price; actual sales prices ranged from $132.84 to $133.829. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F7 Price reflects weighted average sales price; actual sales prices ranged from $133.84 to $134.159. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F8 Includes the following: (1) 109,478 unvested restricted share units ("RSUs"), which will vest in two equal annual installments beginning on June 12, 2026; (2) 94,675 unvested RSUs, which will vest in three equal annual installments beginning on June 12, 2026; and (3) 85,021 unvested RSUs, which will vest on June 14, 2026. F9 Each unvested RSU represents a contingent right to receive one unrestricted, fully transferable share for each vested RSU which has not been previously forfeited. F10 Shares held by a grantor retained annuity trust ("GRAT") of which the reporting person is the trustee. References: F1, F3	S Sale (market/private)Ordinary Shares · Non-derivative	2,797D	130.3008	Direct	Form 4 ↗0001649101-26-000005
2026-05-22Filed 2026-05-26	Advaithi RevathiDirector · Officer · Chief Executive Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on February 20, 2026. F2 Price reflects weighted average sales price; actual sales prices ranged from $128.73 to $129.578. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F3 Price reflects weighted average sales price; actual sales prices ranged from $129.762 to $130.76. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F4 Price reflects weighted average sales price; actual sales prices ranged from $130.83 to $131.77. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F5 Price reflects weighted average sales price; actual sales prices ranged from $131.84 to $132.838. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F6 Price reflects weighted average sales price; actual sales prices ranged from $132.84 to $133.829. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F7 Price reflects weighted average sales price; actual sales prices ranged from $133.84 to $134.159. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F8 Includes the following: (1) 109,478 unvested restricted share units ("RSUs"), which will vest in two equal annual installments beginning on June 12, 2026; (2) 94,675 unvested RSUs, which will vest in three equal annual installments beginning on June 12, 2026; and (3) 85,021 unvested RSUs, which will vest on June 14, 2026. F9 Each unvested RSU represents a contingent right to receive one unrestricted, fully transferable share for each vested RSU which has not been previously forfeited. F10 Shares held by a grantor retained annuity trust ("GRAT") of which the reporting person is the trustee. References: F1, F2	S Sale (market/private)Ordinary Shares · Non-derivative	2,644D	129.1839	Direct	Form 4 ↗0001649101-26-000005
2026-05-22Filed 2026-05-26	McSweeney ErinDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Includes 4,713 unvested restricted share units ("RSUs"), which vest in full on the date immediately prior to the date of Issuer's 2026 annual general meeting. Each unvested RSU represents a contingent right to receive one unrestricted, fully transferrable share for each vested RSU which has not been previously forfeited. References: F1	S Sale (market/private)Ordinary Shares · Non-derivative	2,000D	132.51	Direct	Form 4 ↗0001645325-26-000006
2026-05-14Filed 2026-05-15	McSweeney ErinDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Price reflects weighted average sales price; actual sales prices ranged from $145.65 to $146.11. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price. F2 Includes 4,713 unvested restricted share units ("RSUs"), which vest in full on the date immediately prior to the date of Issuer's 2026 annual general meeting. Each unvested RSU represents a contingent right to receive one unrestricted, fully transferrable share for each vested RSU which has not been previously forfeited. References: F1, F2	S Sale (market/private)Ordinary Shares · Non-derivative	3,000D	145.88	Direct	Form 4 ↗0001645325-26-000004

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.